Medtronic plc (MDT) stock
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 17/303% above fair value
$102.86+1.87 (+1.85%)
Close on Nov 13, 2026Market cap $131.57BP/E 25.3Yield 2.76%
Medtronic EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Medtronic's EPS for the twelve months ending Jul 31, 2026 was $4.07, up 12.1% year over year. For fiscal 2026 it was $3.73, up 3.3% from the year before. Over ten years it grew 4.2% a year on average. The highest annual figure on record is $3.73 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | $3.73 | +3.3% |
| FY2025 | Apr 25, 2025 | $3.61 | +30.8% |
| FY2024 | Apr 26, 2024 | $2.76 | -2.1% |
| FY2023 | Apr 28, 2023 | $2.82 | -24.4% |
| FY2022 | Apr 29, 2022 | $3.73 | +40.2% |
| FY2021 | Apr 30, 2021 | $2.66 | -24.9% |
| FY2020 | Apr 24, 2020 | $3.54 | +3.8% |
| FY2019 | Apr 26, 2019 | $3.41 | +50.2% |
| FY2018 | Apr 27, 2018 | $2.27 | -21.5% |
| FY2017 | Apr 28, 2017 | $2.89 | +16.5% |
| FY2016 | Apr 29, 2016 | $2.48 | +2.9% |
| FY2015 | Apr 24, 2015 | $2.41 | -20.2% |
| FY2014 | Apr 25, 2014 | $3.02 | -10.4% |
| FY2013 | Apr 26, 2013 | $3.37 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $1.14 | +40.7% |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | $0.97 | +18.3% |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | $0.89 | -11.9% |
| Q2 FY2026CQ3 2025 | Oct 24, 2025 | $1.07 | +8.1% |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | $0.81 | +1.2% |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | $0.82 | +67.3% |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | $1.01 | +2.0% |
| Q2 FY2025CQ3 2024 | Oct 25, 2024 | $0.99 | +45.6% |
| Q1 FY2025CQ2 2024 | Jul 26, 2024 | $0.80 | +35.6% |
| Q4 FY2024CQ1 2024 | Apr 26, 2024 | $0.49 | -44.3% |
| Q3 FY2024CQ4 2023 | Jan 26, 2024 | $0.99 | +7.6% |
| Q2 FY2024CQ3 2023 | Oct 27, 2023 | $0.68 | +112.5% |
| Q1 FY2024CQ2 2023 | Jul 28, 2023 | $0.59 | -15.7% |
| Q4 FY2023CQ1 2023 | Apr 28, 2023 | $0.88 | -20.0% |
| Q3 FY2023CQ4 2022 | Jan 27, 2023 | $0.92 | -16.4% |
| Q2 FY2023CQ3 2022 | Oct 28, 2022 | $0.32 | -67.0% |
| Q1 FY2023CQ2 2022 | Jul 29, 2022 | $0.70 | +25.0% |
| Q4 FY2022CQ1 2022 | Apr 29, 2022 | $1.10 | +10.0% |
| Q3 FY2022CQ4 2021 | Jan 28, 2022 | $1.10 | +17.0% |
| Q2 FY2022CQ3 2021 | Oct 29, 2021 | $0.97 | +169.4% |
| Q1 FY2022CQ2 2021 | Jul 30, 2021 | $0.56 | +55.6% |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $1.00 | +108.3% |
| Q3 FY2021CQ4 2020 | Jan 29, 2021 | $0.94 | -33.8% |
| Q2 FY2021CQ3 2020 | Oct 30, 2020 | $0.36 | -64.4% |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $0.36 | -43.8% |
| Q4 FY2020CQ1 2020 | Apr 24, 2020 | $0.48 | -44.8% |
| Q3 FY2020CQ4 2019 | Jan 24, 2020 | $1.42 | +51.1% |
| Q2 FY2020CQ3 2019 | Oct 25, 2019 | $1.01 | +23.2% |
| Q1 FY2020CQ2 2019 | Jul 26, 2019 | $0.64 | -19.0% |
| Q4 FY2019CQ1 2019 | Apr 26, 2019 | $0.87 | -18.7% |
| Q3 FY2019CQ4 2018 | Jan 25, 2019 | $0.94 | – |
| Q2 FY2019CQ3 2018 | Oct 26, 2018 | $0.82 | -44.6% |
| Q1 FY2019CQ2 2018 | Jul 27, 2018 | $0.79 | +6.8% |
| Q4 FY2018CQ1 2018 | Apr 27, 2018 | $1.07 | +27.4% |
| Q3 FY2018CQ4 2017 | Jan 26, 2018 | -$1.03 | -274.6% |
| Q2 FY2018CQ3 2017 | Oct 27, 2017 | $1.48 | +85.0% |
| Q1 FY2018CQ2 2017 | Jul 28, 2017 | $0.74 | – |
| Q4 FY2017CQ1 2017 | Apr 28, 2017 | $0.84 | – |
| Q3 FY2017CQ4 2016 | Jan 27, 2017 | $0.59 | – |
| Q2 FY2017CQ3 2016 | Oct 28, 2016 | $0.80 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?